The current trend of multiple European and US buyers moving away from China is expected to boost the API market of India. Moreover, the 'Make in India' initiative with backward integration of key intermediates, will further accelerate the low-cost API manufacturing in India. With the ongoing scenario, consistent delivery of excellent quality APIs at competitive rates, compliance with the requirements of the global drug regulatory agencies coupled with timely deliveries will be the key. To attain the same, API manufacturers are needed to level up their manufacturing facilities, with emphasis on developing a robust pipeline for quicker turnaround times.
Harshit M Savla
Joint Managing Director, Aarti Drugs
Established in the year 1984 with robust R&D division, the company bacame one of the largest producers in the world for Metformin, Fluroquinolones,Tinidazole, Metronidazole Benzoate and many others
K Nityananda Reddy
Vice Chairman & MD, Aurobindo Pharma
Manufacturer of both generic pharmaceuticals and active pharmaceutical ingredients
K Satish Reddy
Chairman, Dr. Reddy's Laboratories
Providing affordable and innovative medicine to help patients lead a healthier life
Binish Chudgar
Vice Chairman & Managing Director, Intas Pharmaceuticals
One of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world
Pardeep Kumar Khanna
Chief Financial Officer, IOL Chemicals & Pharmaceuticals
One of top pharma API and speciality chemicals manufacturers in the world with presence across various therapeutic categories like, Pain Management, Anti- diabetic, Anti hypertensive and others
Premchand Godha
Chairman & M.D & CEO, Ipca Laboratories
A reliable supply chain and cost competitiveness in the dynamic market have made the company to emerge as one of the India's top API exporters
Mark B Saldanha
Managing Director, Marksans Pharma
An Indian pharmaceutical company having a global footprint whose strength lies in research, manufacturing and marketing of finished dosage pharmaceutical formulations
Sushil Suri
CMD, Morepen
Specializes in API manufacturing and has obtained a niche place in the anti-histamine category
Dilip S Shanghvi
Managing Director, Sun Pharmaceutical Industries
Trying to generate innovative concepts & ideas to harness market needs and synergies across therapeutic areas
Brijnath Chaurasia
Director, Teva API India
Leading international supplier of APIs with more than 350 products in the portfolio
We use cookies to ensure you get the best experience on our website. Read more...